Umstead John W. V

CIK 00019679101 companyRESEARCH TRIANGLE PARK, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001967910

Recent Transactions

18 trades

Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−168,387→ 19,331 total
Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−19,331→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−74,500→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−6,000→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−100,000→ 0 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-07-05$2.51/sh−527→ 187,718 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-07-01+35,000→ 188,245 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-05-13$4.79/sh−8,151→ 153,245 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-03-20+37,500→ 161,396 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-03-18$3.02/sh−6,547→ 123,896 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-04$2.94/sh−111→ 130,443 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-01-03+37,300→ 131,186 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−253→ 130,933 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−379→ 130,554 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-01-03+74,500→ 74,500 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-05-10+35,000→ 93,886 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-03-15+50,000→ 58,886 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2023-03-15+100,000→ 100,000 total

Companies

G1 Therapeutics, Inc.
Chief Financial Officer

Recent Filings

Address

700 PARK OFFICES DRIVE, SUITE 200

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov